Research Paper Volume 15, Issue 9 pp 3410—3426
Development and validation of a novel anoikis-related gene signature for predicting prognosis in ovarian cancer
Figure 7. The correlation between the signature and TIME in TCGA cohort. (A) Comparison of StromalScore, ImmuneScore, ESTIMATEScore and TumorPurity between the HRisk and LRrisk patients. (B) Comparison of TCR richness between the HRisk and LRrisk patients. (C) Boxplots depicting the CIBERSORT scores of 22 immune cells of the HRisk patients compared to LRrisk patients. (Wilcoxon test, Adjusted P values were showed as: ns, not significant; *, p< 0.05; **, p < 0.01; ***, p < 0.001).